SRPT : Summary for Sarepta Therapeutics, Inc. - Yahoo Finance

U.S. Markets close in 5 hrs 42 mins

Sarepta Therapeutics, Inc. (SRPT)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
33.78-1.04 (-2.99%)
As of 10:18 AM EST. Market open.
People also watch:
ACADCLVSPTCTCLDXICPT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close34.82
Open34.12
Bid33.54 x 200
Ask33.61 x 100
Day's Range33.40 - 34.94
52 Week Range8.00 - 63.73
Volume294,025
Avg. Volume4,413,568
Market Cap1.84B
Beta2.01
PE Ratio (TTM)-6.42
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Hedge Funds Are Crazy About Sarepta Therapeutics Inc (SRPT)
    Insider Monkey6 hours ago

    Hedge Funds Are Crazy About Sarepta Therapeutics Inc (SRPT)

    It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. The Standard and Poor’s 500 Index returned 7.6% over […]

  • Is This Why Sarepta Therapeutics Fell 14.5% in November?
    Motley Fool2 days ago

    Is This Why Sarepta Therapeutics Fell 14.5% in November?

    Shares of the rare-disease-focused drugmaker fell by double digits on little news. Was the decline caused by building skepticism regarding Sarepta's ability to get broad insurance coverage for Exondys 51?

  • Investopedia5 days ago

    Sarepta Drug Gets UnitedHealth Coverage (SRPT, UNH)

    At long last! Sarepta's muscular dystrophy drug Exondys 51 finally got coverage by UnitedHealth insurance.